Type to search

Medtronic Announces FDA Approval of its Next Generation Recharge-Free Spinal Cord Stimulation Platform | Pharmtech Focus
Onxeo Receives Notice of Allowance for a New Patent Broadening the Protection of AsiDNA™ in combination with a PARP Inhibitor in the United States | Pharmtech Focus
FDA Approval of Aducanumab | Pharmtech Focus